US Patent Issued to Anbogen Therapeutics on Sept. 29 for "Pharmaceutical kits and uses thereof for treating colorectal cancer" (Taiwanese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,226, issued on Sept. 29, was assigned to Anbogen Therapeutics Inc. (Taipei City, Taiwan).

"Pharmaceutical kits and uses thereof for treating colorectal cancer" was invented by Tsu-An Hsu (Taipei City, Taiwan), Sue-Ming Chang (Taipei City, Taiwan), Chien-Ting Lin (Taipei City, Taiwan) and Meng-Chieh Lin (Taipei City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure in general describes a pharmaceutical kit for treating colorectal cancer; the pharmaceutical kit comprises (E)-N-hydroxy-3-(1-(phenylsulfonyl)-indolin-5-yl)-acrylamide, and an anti-PD-1 or anti-PD-L1 antibody. Furthermore, this disclosure describes a method for treati...